|Day Low/High||65.93 / 67.58|
|52 Wk Low/High||45.60 / 67.91|
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AOI, ATSG, CKH, CRM, DDS, EQBK, FSTR, GNK, NEWM, OAS, RDC, RRC, TCMD, UHS, WTW Downgrades: AHGP, AMED, AXE, CTRE, CULP, DOC, EMKR, GLW, HABT, IT, KBR, RP, SGEN, SPOK, SWM, TACO, UGP, UTHR Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Paul Kusserow, CEO of home health care provider Amedysis and a former Humana executive, thinks CVS Health's agreement to buy Aetna, announced on Monday, is "very exciting."
The most recent short interest data has been released for the 11/15/2017 settlement date, which shows a 350,029 share decrease in total short interest for Amedisys, Inc. , to 2,541,688, a decrease of 12.10% since 10/31/2017.
In recent trading, shares of Amedisys, Inc. have crossed above the average analyst 12-month target price of $57.25, changing hands for $58.49/share.
158 Amedisys Home Health Care Centers Recognized
The most recent short interest data has been released for the 07/31/2017 settlement date, which shows a 553,082 share decrease in total short interest for Amedisys, Inc. , to 2,731,061, a decrease of 16.84% since 07/14/2017.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.